2011 Valuation Survey of North American Angel Groups
Gust
OCTOBER 12, 2011
Biotech, life science and medical devices are usually funded at higher pre-money valuations than, say, software and Internet companies. 3) Some groups invest $2 million or more in pre-revenue companies, while others typically invest less than $500,000 in these very early stage ventures. Fargo/Morehead Angels. Maple Leaf Angels.
125 
Let's personalize your content